Keith M. Borkett

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

Norbert Schmitz, Peter Dreger, David C. Linch et al. · The Lancet · 1996 · 615 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +10

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

Laurie J. Antonik, D. Ronald Goldwater, Gavin J. Kilpatrick et al. · Anesthesia & Analgesia · 2011 · 353 citations

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Norbert Schmitz, Andrea Bacigalupo, Dirk Hasenclever et al. · Bone Marrow Transplantation · 1998 · 264 citations

Cell Therapy, Transplantation, Marrow Transplantation +8

A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy

Keith M. Borkett, Dennis Riff, Howard I. Schwartz et al. · Anesthesia & Analgesia · 2014 · 226 citations

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

Hugh Wiltshire, Gavin J. Kilpatrick, Gary S Tilbrook et al. · Anesthesia & Analgesia · 2012 · 206 citations